2030年までの欧州神経刺激装置市場予測 - 地域分析 - 製品別(脊髄刺激装置、脳深部刺激装置、仙骨神経刺激装置、迷走神経刺激装置など)、用途別(疼痛管理、てんかん、尿失禁、便失禁、パーキンソン病)病気など)、エンドユーザー(病院、専門クリニックなど)

BMIRE00030035 | Pages: 91 | Medical Device | Apr 2024 | Type: Regional | Status: Published
ヨーロッパの神経刺激装置市場は、2022 年に 17 億 1,784 万米ドルと評価され、2030 年までに 34 億 5,924 万米ドルに達すると予想されています。 2022年から2030年までに9.1%のCAGRを記録すると推定されています。 脊髄損傷の増加が欧州の神経刺激装置市場を牽引 神経刺激装置業界は、さまざまな脊椎疾患にかかりやすい高齢者人口の増加により牽引力を増しています。これらの人々は、椎間板変性疾患、変形性関節症、側弯症、脊椎腫瘍、脊柱管狭窄症などの脊椎疾患を発症しやすくなっています。この人口が高齢化するにつれて、脊椎の自然な磨耗により、いくつかの脊椎疾患が引き起こされる可能性があります。したがって、この事実により、人口の高齢化は、複数の虚弱性、合併症、栄養状態の低下、および術後合併症の可能性の高さの増加により、脊椎外科医にとって独特の課題となっています。 2022 年 10 月に発表された世界保健機関 (WHO) のデータによると、2050 年までに高齢者人口の約 80% が低・中所得国に住むことになり、この人口高齢化のペースはさらに速くなることが予想されています。昔よりも早くなりました。人口の高齢化にライフスタイル関連の要因が加わり、椎間板変性疾患や脊椎変形などの脊椎の問題を経験する人が大幅に増加しています。したがって、高齢者や成人における脊髄損傷の発生率が高いため、神経刺激装置の需要が刺激されています。ヨーロッパの神経刺激デバイス市場の概要 ヨーロッパの神経刺激デバイス市場は、英国、ドイツ、フランス、イタリア、スペイン、およびその他のヨーロッパに分割されています。この地域の市場は、脳動脈瘤や脳卒中などの神経疾患の有病率の上昇と、この地域で活動する市場プレーヤーによる製品イノベーションの増加により、今後数年間で大幅に成長すると予想されています。市場の成長は、ドイツ、フランス、スペインなどの国々での医療システムの発展と、主要な地域企業による革新的な製品の発売の増加にも起因しています。 2020 年 6 月、メドトロニックは、BrainsenseTM テクノロジーを搭載した PerceptTM PC Neurostimulator の発売を発表しました。この技術は、パーキンソン病 (PD) の症状を軽減するために、電気刺激を記録し、脳に伝達することを同時に行います。ヨーロッパの神経刺激デバイス市場の収益と2030年までの予測(百万米ドル) ヨーロッパの神経刺激デバイス市場のセグメンテーション ヨーロッパの神経刺激デバイス市場は、製品、アプリケーション、エンドユーザー、および国に基づいて分割されています。製品に基づいて、ヨーロッパの神経刺激装置市場は脊髄刺激装置、脳深部刺激装置、仙骨神経刺激装置、迷走神経刺激装置などに分類されます。脊髄刺激装置セグメントは、2022年に最大の市場シェアを獲得しました。用途の観点から見ると、ヨーロッパの神経刺激装置市場は、疼痛管理、てんかん、尿失禁、便失禁、パーキンソン病などに分類されます。疼痛管理セグメントは、2022 年に最大の市場シェアを保持しました。ヨーロッパの神経刺激装置市場は、エンドユーザーごとに病院、専門クリニックなどに分割されています。病院セグメントは、2022 年に最大の市場シェアを保持しました。国に基づいて、ヨーロッパの神経刺激デバイス市場は英国、ドイツ、フランス、イタリア、スペイン、およびその他のヨーロッパに分割されています。 2022 年の欧州神経刺激装置市場シェアはドイツが独占しました。Medtronic Plc、Boston Scientific Corp、Abbott Laboratories、Nevro Corp、LivaNova Plc、Synapse Biomedical Inc、ElectroCore Inc、Mainstay Medical は、欧州神経刺激装置市場で事業を展開する大手企業です。 。
Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Neurological Disorders

4.1.2 Rising Cases of Spinal Cord Injury

4.2 Market Restraints

4.2.1 Lack of Expert Professionals

4.3 Market Opportunities

4.3.1 Growing Advances and Approvals for Neurostimulation Devices

4.4 Future Trends

4.4.1 Rising Demand for Noninvasive Treatment

4.5 Impact Analysis

5. Neurostimulation Devices Market - Europe Market Analysis

5.1 Europe Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Spinal Cord Stimulator

6.3.1 Overview

6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Deep Brain Stimulator

6.4.1 Overview

6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Sacral Nerve Stimulator

6.5.1 Overview

6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vagus Nerve Stimulator

6.6.1 Overview

6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Pain Management

7.3.1 Overview

7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Epilepsy

7.4.1 Overview

7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Urinary and Fecal Incontinence

7.5.1 Overview

7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Parkinson's Disease

7.6.1 Overview

7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Specialty Clinics

8.4.1 Overview

8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Europe: Neurostimulation Devices Market

9.1.1 Overview

9.1.2 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

9.1.2.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott Laboratories

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Nevro Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 LivaNova Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Synapse Biomedical Inc.

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 ElectroCore Inc

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Mainstay Medical

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Neurostimulation Devices Market Segmentation

Table 2. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 3. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 4. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 5. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 6. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 12. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 13. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 15. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, Neurostimulation Devices Market

List of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country

Figure 2. Neurostimulation Devices Market: Key Industry Dynamics

Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints

Figure 4. Europe Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Europe Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Europe Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)

Figure 22. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

Figure 23. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

1. Medtronic Plc

2. Boston Scientific Corp

3. Abbott Laboratories

4. Nevro Corp

5. LivaNova Plc

6. Synapse Biomedical Inc

7. ElectroCore Inc

8. Mainstay Medical

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe neurostimulation devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe neurostimulation devices market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
  • Report Code
    Full Name
    Country Name
    Email Id
    Phone Number
    Job Title
    Company
    Requirement

    Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


    Purchase Options
    Single User License
    $3550
    $2840
    Site License
    $4550
    $3640
    Enterprise License
    $5550
    $4440